Bristol-Myers Inks $10M Deal To End Drug Antitrust Claims

By Nadia Dreid · November 5, 2021, 9:59 PM EDT

Bristol-Myers Squibb has reached a $10 million settlement to escape claims that it conspired with rivals to keep a blockbuster HIV treatment off the market, and both sides are hoping that...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login